- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01658397
The Effect of Calorie Deprivation on Adipose Tissue Distribution
February 8, 2017 updated by: Pouneh K. Fazeli, MD, Massachusetts General Hospital
In this study, we will be studying the effects of acute calorie deprivation (a 10-day fast) on bone marrow fat, other fat stores and bone parameters.
We will be measuring changes in bone marrow fat using magnetic resonance spectroscopy and will use MRI to measure subcutaneous and visceral fat depots.
Our hypothesis is that levels of bone marrow fat will increase after an acute fast.
Study Overview
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women, ages 21-45 years
- 101-130% of ideal body weight as defined by the 1983 Metropolitan Life Insurance Height and Weight Tables
- Normal thyroid function
- Regular menses (women)
- Normal liver transaminases
Exclusion Criteria:
- Any disease known to affect bone metabolism, including untreated thyroid dysfunction, Cushing's syndrome, or renal failure
- Any medication known to affect bone metabolism -- including systemic steroids or immunosuppressants -- within three months of the study, excluding estrogen and progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be excluded from participating for six months after their last injections. Bisphosphonates must have been discontinued for at least one year before participation
- Serum potassium <3.0 meq/L
- Pregnant and/or breastfeeding (women)
- Diabetes mellitus
- Active substance abuse, including alcohol
- Contraindications to MRI: cardiac pacemaker, metal implants, claustrophobia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fasting
Ten day fast
|
Ten day fast
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Bone Marrow Adiposity over 10 day fasting period
Time Frame: Baseline, After 10 day fasting period
|
Bone marrow adiposity will be measured before and after the 10 day fast using magnetic resonance spectroscopy.
|
Baseline, After 10 day fasting period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
July 21, 2014
Study Completion (Actual)
July 21, 2014
Study Registration Dates
First Submitted
August 1, 2012
First Submitted That Met QC Criteria
August 6, 2012
First Posted (Estimate)
August 7, 2012
Study Record Updates
Last Update Posted (Actual)
February 10, 2017
Last Update Submitted That Met QC Criteria
February 8, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2010P001066
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.